Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Next-generation sequencing identified a novel CACNA1A I1379F variant in a familial hemiplegic migraine type 1 pedigree: A case report.

Journal: Medicine
Published: December 23, 2021

Familial hemiplegic migraine.

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 30, 2021

Functional correlation of ATP1A2 mutations with phenotypic spectrum: from pure hemiplegic migraine to its variant forms.

Journal: The journal of headache and pain
Published: August 13, 2021

CACNA1A-p.Thr501Met mutation associated with familial hemiplegic migraine: a family report.

Journal: The journal of headache and pain
Published: July 29, 2021

A case report of atypical hemiplegic migraine with nonheadache onset in a Chinese child.

Journal: BMC neurology
Published: July 07, 2021

Clinical and genetic analysis of 5 pediatric patients with hemiplegic migraine presenting as acute encephalopathy.

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: March 29, 2021

Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2.

Journal: The journal of headache and pain
Published: March 13, 2021

Comprehensive Exonic Sequencing of Hemiplegic Migraine-Related Genes in a Cohort of Suspected Probands Identifies Known and Potential Pathogenic Variants.

Journal: Cells
Published: October 31, 2020

Familial hemiplegic migraine with a PRRT2 mutation: Phenotypic variations and carbamazepine efficacy.

Condition: Familial Hemiplegic Migraine
Journal: Brain & development
Treatment Used: Low-dose Carbamazepine
Number of Patients: 0
Published: January 07, 2020

Early Treatment in Acute Severe Encephalopathy Caused by ATP1A2 Mutation of Familial Hemiplegic Migraine Type 2: Case Report and Literature Review.

Condition: Acute Severe Encephalopathy Caused by ATP1A2 Mutation of Familial Hemiplegic Migraine Type 2 (FHM2)
Journal: Neuropediatrics
Treatment Used: Early Treatment Preventing Glutamatergic Excitotoxicity and Protection of Mitochondria Function and Antimigraine Drug
Number of Patients: 1
Published: November 26, 2019
Showing 1-10 of 10

Last Updated: 02/19/2023